Leo Beletsky on Muck Rack

Leo Beletsky

Boston, Cope
As seen in: MSN, National Institutes of Health, The New York Times, HuffPost, Scribd, USA Today, Wiley, Harm Reduction Journal, Harvard Health Publishing, Los Angeles Times and
Public health impact of laws & law enforcement @NUSL @hijAction @NUbouve @UCSDMedSchool | Harm reductionist | Nomad | Dad to 2 bandits & cat ⛵
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Leo

Contact Leo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

State Policies Regulating Law Enforcement Access to Prescription Drug Monitoring Program Testosterone Prescription Data

|
By Katie McCreedy, Bouve College, Elizabeth Alison Platt, Leo Beletsky
| JAMA: Journal of the American Medical Association
State Policies Regulating Law Enforcement Access to Prescription Drug Monitoring Program Testosterone Prescription Data Testosterone replacement therapy is prescribed for men with hypogonadism and transgender men. For transgender youths, testosterone and other gender-affirming medical interventions are associated with lower odds of suicidality.1 However, more states are adopting policies restricting and criminalizing gender-affirming care, especially for minors.
Open in Who Shared Issue with article?

Reclassifying cannabis as a Schedule III drug only exacerbates a bad situation

|
By Leo Beletsky, Shaleen Title, Shanel Lindsay
| The Korea Times (Korea)
By Leo Beletsky, Shaleen Title and Shanel Lindsay For the first time in decades, there are positive signs that the overdose crisis is finally slowing. What’s behind this progress is subject to debate, but one of its likely drivers is policy reform. Recent changes in our outdated laws have reduced barriers to life-saving drug treatment medications, improved access to the overdose antidote naloxone, and authorized other proven harm reduction measures.
Open in Who Shared View Duplicates (3) Issue with article?

Reclassifying cannabis as a Schedule III drug only exacerbates a bad situation

|
By Leo Beletsky, Shaleen Title, Shanel Lindsay
| Frederick News Post
For the first time in decades, there are positive signs that the overdose crisis is finally slowing. What’s behind this progress is subject to debate, but one of its likely drivers is policy reform. Recent changes in our outdated laws have reduced barriers to life-saving drug treatment medications, improved access to the overdose antidote naloxone, and authorized other proven harm reduction measures. kAm~?6 @7 E96 >@DE ?@E23=6 C67@C>D 92D 366? E96 C2A:5 D42=6\FA :?
Open in Who Shared Issue with article?
See all 103 licensed articles (112 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Leo

Contact Leo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified